SV Health Investors, LLC

Q4 2017 13F Holdings Report, Stock Holdings

Signature - Title
Brent M. Faduski - Officer
Location
Boston, MA
Holdings as of
December 31, 2017
Value $
$189M
Num holdings
8
Date filed
2/14/2018, 11:24 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2017 - Nov 14, 2017
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2017 Q4 compared to 2017 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Denise W. Marks CFO Boston, Massachusetts 2/14/2018

The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Health Investors, LLC (formerly SV Life Sciences Advisers, LLC), a Delaware limited liability company ("Investors"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP 1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co- Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), and SV Life Sciences Fund VI, L.P. ("SVLS VI LP") and SV Life Sciences Fund VI Strategic Partners, L.P. ("Strategic Partners VI" and together with SVLS VI LP, the "Fund VI Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund III Entities, the Fund V Entities and the Fund VI Entities together, the "Funds"), directly own certain security positions reported by Investors, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Investors are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Investors may be deemed to share voting power and control over the shares held by the Fund IV Entities. Investors may also be deemed to share voting power and control over the shares held by the Fund III Entities, the Fund V Entities and the Fund VI Entities. Each of SVLS IV GP, SVLSF IV, LLC and Investors disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein.

List of Other Managers Reporting for SV Health Investors, LLC:

Name Holdings Value Location File Number
SV Life Sciences Fund VI (GP), L.P. Boston, MA 028-19255
SVLSF VI, LLC Boston, MA 028-19256

Other Included Managers (2):

Num Name File Number
1 SVLSF IV, LLC 028-16272
2 SV Life Sciences Fund IV (GP), L.P. 028-16273